TY - JOUR
T1 - Cervical adenocarcinoma survival among Hispanic and white women
T2 - A multicenter cohort study
AU - Schorge, John O.
AU - Lea, Jayanthi S.
AU - Garner, Elizabeth O.
AU - Duska, Linda R.
AU - Miller, David S.
AU - Coleman, Robert L.
PY - 2003/3/1
Y1 - 2003/3/1
N2 - OBJECTIVE: We compared the clinical outcome of cervical adenocarcinoma in Hispanic and white women to determine whether race was an independent predictor of survival. STUDY DESIGN: All women who were diagnosed with cervical adenocarcinoma at three institutions between 1982 and 2000 were identified. Medical records were reviewed retrospectively. Hispanic and white cohorts were matched 1:2 for age, stage of disease, date of diagnosis, tumor size, histologic subtype, grade, and invasive depth. RESULTS: The 65 Hispanic patients were more likely to be treated at the public hospital (71% vs 14%; P < .001) than the 122 matched white patients. Most Hispanic patients (72%) and white patients (76%) presented with early (stage IA-IIA), not advanced (IIB-IVB), disease. Early (81% vs 81%, P = .65), advanced (37% vs 26%, P = .21), and overall 5-year survival rates (67% vs 68%, P = .57) were similar among Hispanic and white patients, respectively. The relative risk of race on recurrence was 1.22 (95% Cl, 0.56-2.42) and on survival was 0.72 (95% Cl, 0.36-1.44). CONCLUSION: Hispanic race is not an independent predictor of survival in cervical adenocarcinoma.
AB - OBJECTIVE: We compared the clinical outcome of cervical adenocarcinoma in Hispanic and white women to determine whether race was an independent predictor of survival. STUDY DESIGN: All women who were diagnosed with cervical adenocarcinoma at three institutions between 1982 and 2000 were identified. Medical records were reviewed retrospectively. Hispanic and white cohorts were matched 1:2 for age, stage of disease, date of diagnosis, tumor size, histologic subtype, grade, and invasive depth. RESULTS: The 65 Hispanic patients were more likely to be treated at the public hospital (71% vs 14%; P < .001) than the 122 matched white patients. Most Hispanic patients (72%) and white patients (76%) presented with early (stage IA-IIA), not advanced (IIB-IVB), disease. Early (81% vs 81%, P = .65), advanced (37% vs 26%, P = .21), and overall 5-year survival rates (67% vs 68%, P = .57) were similar among Hispanic and white patients, respectively. The relative risk of race on recurrence was 1.22 (95% Cl, 0.56-2.42) and on survival was 0.72 (95% Cl, 0.36-1.44). CONCLUSION: Hispanic race is not an independent predictor of survival in cervical adenocarcinoma.
KW - Cervical adenocarcinoma
KW - Cohort study
KW - Racial difference
UR - http://www.scopus.com/inward/record.url?scp=0037343041&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037343041&partnerID=8YFLogxK
U2 - 10.1067/mob.2003.96
DO - 10.1067/mob.2003.96
M3 - Article
C2 - 12634634
AN - SCOPUS:0037343041
SN - 0002-9378
VL - 188
SP - 640
EP - 644
JO - American Journal of Obstetrics and Gynecology
JF - American Journal of Obstetrics and Gynecology
IS - 3
ER -